Medical Innovation Exchange

POINT well made: Lantheus promises up to $2B for 2 of the biotech's cancer radiopharmaceutical therapies

https://www.fiercebiotech.com/biotech/point-well-made-lantheus-signs-2b-deal-2-biotechs-cancer-radiopharmaceutical-therapies

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!